The flow-responsive transcription factors KLF2 and KLF4 play an important role in restricting endothelial dysfunction, inflammation, thrombosis, and angiogenesis in response to disturbed flow [34,35]. The gene discussed is KLF4; the disease is endothelial dysfunction.